About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have two novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

October 3, 2018

DS Biopharma announces positive top-line phase 2b trial results for DS107 as a topical treatment for mild to moderate atopic dermatitis

DS Biopharma announces positive top-line phase 2b trial results for DS107 as a topical treatment for mild to moderate atopic dermatitis Dublin, Ireland, October 3rd 2018 […]
December 11, 2017

DS Biopharma receives a patent allowance for DS109 in the US

Dublin, Ireland, December 11th, 2017 – DS Biopharma (DS), a clinical stage biopharmaceutical company, today announced receipt of allowance for a patent application in the United […]

Join our mailing list

Connect with us